Retatrutide is a next-generation research peptide designed to activate three key metabolic receptors: GLP-1, GIP, and glucagon. By targeting these pathways at the same time, it has attracted significant attention in scientific studies focused on metabolism, appetite regulation, and energy balance.
In research models and clinical studies, retatrutide has been explored for its ability to help regulate appetite, increase energy expenditure, and support metabolic health. Because of its powerful triple-receptor mechanism, it has quickly become one of the most promising peptides studied in modern metabolic and weight-management research.
Each vial contains research-grade lyophilized peptide with ≥99% purity.
